Works matching IS 02770008 AND DT 2019 AND VI 39 AND IP 5

Results: 11

Effects of Norepinephrine and Vasopressin Discontinuation Order in the Recovery Phase of Septic Shock: A Systematic Review and Individual Patient Data Meta‐Analysis.
Published in:
Pharmacotherapy, 2019, v. 39, n. 5, p. 544, doi. 10.1002/phar.2265
By:
- Hammond, Drayton A.;
- Sacha, Gretchen L.;
- Bissell, Brittany D.;
- Musallam, Nadine;
- Altshuler, Diana;
- Flannery, Alexander H.;
- Lam, Simon W.;
- Bauer, Seth R.
Publication type:
Article
Critique of Vancomycin Dose‐Optimizing Software Review.
Published in:
2019
By:
- McLeay, Robert C.
Publication type:
Letter to the Editor
Dr. Turner Responds to Dr. McLeay.
Published in:
2019
By:
- Turner, R. Brigg;
- Elbarbry, Fawzy
Publication type:
Letter to the Editor
Association Between Time‐in‐Therapeutic Tacrolimus Range and Early Rejection After Heart Transplant.
Published in:
Pharmacotherapy, 2019, v. 39, n. 5, p. 609, doi. 10.1002/phar.2262
By:
- Baker, William L.;
- Steiger, Samantha;
- Martin, Spencer;
- Patel, Nirav;
- Radojevic, Joseph;
- Darsaklis, Konstadina;
- O'Bara, Lynn;
- Kutzler, Heather;
- Dougherty, James;
- Feingold, Andrew;
- Hammond, Jonathan;
- Fusco, Daniel;
- Gluck, Jason A
Publication type:
Article
Fixed‐Dose Four‐Factor Prothrombin Complex Concentrate for Vitamin K Antagonist Reversal: Does One Dose Fit All?
Published in:
Pharmacotherapy, 2019, v. 39, n. 5, p. 599, doi. 10.1002/phar.2261
By:
- Schwebach, Alyson A.;
- Waybright, Ryan A.;
- Johnson, Thomas J.
Publication type:
Article
Evaluation of Clinical and Safety Outcomes Following Uncontrolled Tacrolimus Conversion in Adult Transplant Recipients.
Published in:
Pharmacotherapy, 2019, v. 39, n. 5, p. 564, doi. 10.1002/phar.2260
By:
- Lichvar, Alicia;
- Tremblay, Simon;
- Naik, Devanshi;
- Lipscomb, Jessi;
- King, Eileen;
- Vinks, Alexander A.;
- Christians, Uwe;
- Alloway, Rita R.
Publication type:
Article
Prechemotherapy Levels of Plasma Dehydroepiandrosterone and Its Sulfated Form as Predictors of Cancer‐Related Cognitive Impairment in Patients with Breast Cancer Receiving Chemotherapy.
Published in:
Pharmacotherapy, 2019, v. 39, n. 5, p. 553, doi. 10.1002/phar.2259
By:
- Toh, Yi Long;
- Shariq Mujtaba, Juliana;
- Bansal, Sumit;
- Yeo, Angie;
- Shwe, Maung;
- Lau, Aik Jiang;
- Chan, Alexandre
Publication type:
Article
Integrase Inhibitors: After 10 Years of Experience, Is the Best Yet to Come?
Published in:
Pharmacotherapy, 2019, v. 39, n. 5, p. 576, doi. 10.1002/phar.2246
By:
- Brooks, Kristina M.;
- Sherman, Elizabeth M.;
- Egelund, Eric F.;
- Brotherton, Amy;
- Durham, Spencer;
- Badowski, Melissa E.;
- Cluck, David B.
Publication type:
Article
Risk of Gynecomastia with Users of Proton Pump Inhibitors.
Published in:
Pharmacotherapy, 2019, v. 39, n. 5, p. 614, doi. 10.1002/phar.2245
By:
- He, Bonnie;
- Carleton, Bruce;
- Etminan, Mahyar
Publication type:
Article
The Association Between Central Nervous System‐Active Medication Use and Fall‐Related Injury in Community‐Dwelling Older Adults with Dementia.
Published in:
Pharmacotherapy, 2019, v. 39, n. 5, p. 530, doi. 10.1002/phar.2244
By:
- Hart, Laura A.;
- Marcum, Zachary A.;
- Gray, Shelly L.;
- Walker, Rod L.;
- Crane, Paul K.;
- Larson, Eric B.
Publication type:
Article
Issue Information.
Published in:
Pharmacotherapy, 2019, v. 39, n. 5, p. 527, doi. 10.1002/phar.2136
Publication type:
Article